Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Favorable seven-year data for transcatheter aortic valves and competitor exits support a high likelihood of double-digit earnings growth.
— David A. Rolfe, Michael X. Quigley, Christopher T. Jersan
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Edwards Lifesciences Corp.
More institutional theses from Wedgewood Partners
Apple Inc. ($AAPL) represents 7.60% of the portfolio. Apple designs, manufactures,...
Microsoft Corporation ($MSFT) represents 7.50% of the portfolio. The company provides...
Meta Platforms ($META) represents 8.34% of the fund's portfolio. Meta operates the...